From there, KDIGO supports what is often described as a four-pillar framework in T2D CKD: RAAS inhibition as the base, followed by SGLT2 inhibitors, non-steroidal MRAs for T2D with albuminuric CKD, and GLP-1 receptor agonists for T2D with CKD layered to reduce kidney and cardiovascular risk
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies
National Cancer Institute FactSheet
To put that in perspective, this level of weight reduction is comparable to what can be seen after some forms of bariatric surgery, but achieved through a peptide-based therapy
It helps prevent peptide aggregation, the process where tirzepatide molecules clump together and lose their effectiveness
Measurement of serum methylmalonic acid should be used to confirm deficiency in asymptomatic high-risk patients with low-normal levels of vitamin B 12